Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Influence of infection on exacerbations of multiple sclerosis.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Women's Issues in Multiple Sclerosis.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Dimethylfumarate induces apoptosis in human mast cells.
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.

Pages